Onkologie und Hämatologie | Zeitschrift memo - Magazine of European Medical Oncology Ausgabe 1/2018 Inhaltsverzeichnis ( 19 Artikel ) 27.02.2018 | Onkologie | editorial | Ausgabe 1/2018 Revival of anti-angiogenic therapies in cancer News from an old therapeutic concept—part 2 Andreas Pircher MD PhD 23.02.2018 | Onkologie | editorial | Ausgabe 1/2018 Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes Ursula M. Vogl MD 02.03.2018 | editorial | Ausgabe 1/2018 In need of special care: adolescent and young adult patients with cancer Assoc. Prof. Michael N. Dworzak M.D., Ph.D. 05.01.2018 | editorial | Ausgabe 1/2018 memo—publisher’s report 2017 Alois Sillaber 23.02.2018 | short review | Ausgabe 1/2018 Targeting angiogenesis in lung cancer Sameh Daher MD, Jair Bar MD, PhD 02.02.2018 | short review | Ausgabe 1/2018 Open Access Anti-angiogenic therapies in brain metastases Anna S. Berghoff MD, PhD, Matthias Preusser MD PDF-Version jetzt herunterladen Zum Volltext 23.02.2018 | short review | Ausgabe 1/2018 Antiangiogenic therapies in ovarian cancer Adriaan Vanderstichele MD, Siel Olbrecht MD, Ignace Vergote MD PhD 22.12.2017 | review | Ausgabe 1/2018 Open Access My burning issues in the neoadjuvant treatment for breast cancer Elisabeth S. Bergen, Rupert Bartsch PDF-Version jetzt herunterladen Zum Volltext 21.12.2017 | editorial | Ausgabe 1/2018 My burning issues in TKI therapy and treatment-free remission in CML Dominik Wolf MD 21.02.2018 | short review | Ausgabe 1/2018 Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer PD Dr. med. univ. Peter Horak PhD 08.01.2018 | case report | Ausgabe 1/2018 Local therapy of stage IV renal cell cancer: a case report Muna Ferner, Andrea Vera Keck, Dora Niedersüß-Beke, Kathrin Strasser-Weippl 08.03.2018 | short review | Ausgabe 1/2018 Open Access PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer Irene Resch, Shahrokh F. Shariat, Kilian M. Gust PDF-Version jetzt herunterladen Zum Volltext 02.08.2017 | review | Ausgabe 1/2018 Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia Characteristics and treatment outcome Mirella Ampatzidou M.D., Charikleia Kelaidi, Michael N. Dworzak, Sophia Polychronopoulou 21.02.2018 | review | Ausgabe 1/2018 Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood Edit Bardi MD, Ph.D, Assoc. Prof. Leo Kager MD 21.02.2018 | short review | Ausgabe 1/2018 Open Access Short overview on the current standard of treatment in newly diagnosed multiple myeloma Dr. med. Ella Willenbacher, Dr. med. Agnes Balog, Dr. med. Wolfgang Willenbacher PDF-Version jetzt herunterladen Zum Volltext 20.09.2017 | review | Ausgabe 1/2018 Cell free nucleic acids as diagnostic and prognostic marker in leukemia Maryam Eini, Seyed Ali Nojoumi, Mohammad-Amin Saki, Abbas Khosravi 21.02.2018 | case report | Ausgabe 1/2018 Open Access Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity Malik Ghannam MBBCh, Maria Bryan MS, Erik Kuross DO, Brent Berry MD/PhD PDF-Version jetzt herunterladen Zum Volltext 16.02.2018 | comment | Ausgabe 1/2018 Open Access ESMO 2017—my personal highlights Barbara Kiesewetter M.D., Mircea Dediu M.D., Rupert Bartsch M.D. PDF-Version jetzt herunterladen Zum Volltext 21.02.2018 | Publisher Correction | Ausgabe 1/2018 Correction to: Report from the WCLC 2017 Congress, Yokohama, 15th–18th October, 2017 Springer-Verlag GmbH Austria
